Keywords : vitamin, folic acid, Vitamin D, Carotenoid, Vitamin E
The global functional foods market continues to develop at a fast pace with growth outstripping that of conventional foods, and product innovation rife. The EU Nutrition and Health Claims Directive’s strict approach to health claims however will clearly influence the future development of the sector, and heightens the need for the latest intelligence. Heart health continues to attract the highest attention of food manufacturers and ingredients ...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
The global functional foods market continues to develop at a fast pace with growth outstripping that of conventional foods, and product innovation rife. The EU Nutrition and Health Claims Directive’s strict approach to health claims however will clearly influence the future development of the sector, and heightens the need for the latest intelligence. Heart health continues to attract the highest attention of food manufacturers and ingredients suppliers worldwide with cholesterol-lowering and omega-3 fortified foods being two of the more established functional foods sectors globally. This report covers developments in the US, Japan, Australia and Europe, including latest market data and key market drivers, product trends, the regulatory environment, ingredients and patents, and future prospects.
Global Vitamin And Supplement Industry
1. INTRODUCTION
2. EXECUTIVE SUMMARY
2.1 Market Size and Segmentation
2.2 Key Market Drivers
2.3 Innovation and New Product Development
2.4 The Regulatory Environment
2.5 Industry Dynamics
2.6 Future Prospects
3. MARKET SITUATION
3.1 Overview
3.2 Cereal Products
3.2.1 Overview
3.2.2 Europe
3.2.4 Japan
3.2.5 Australia
3.3 Fats and Oils
3.3.1 Overview
3.3.2 Europe
3.3.3 US
3.3.4 Japan
3.3.5 Australia
3.4 Fish and Eggs
3.4.1 Overview
3.4.2 Europe
3.4.3 US
3.4.4 Japan
3.4.5 Australia
3.5 Bakery Products
3.5.1 Overview
3.5.2 Europe
3.5.3 US
3.5.4 Japan
3.5.5 Australia
3.6 Soya Products
3.6.1 Overview
3.6.2 Europe
3.6.3 US
3.6.4 Japan
3.6.5 Australia
3.7 Dairy Products
3.7.1 Overview
3.7.2 Europe
3.7.3 US
3.7.4 Japan
3.7.5 Australia
3.8 Soft Drinks
3.8.1 Overview
3.8.2 Europe
3.8.3 US
3.8.4 Japan
3.8.5 Australia
3.9 Confectionery
3.9.1 Overview
3.9.2 Europe
3.9.3 US
3.9.4 Japan
3.9.5 Australia
4. PRODUCT TRENDS
4.1 Overview
4.1.1 Europe
4.1.2 US
4.1.3 Japan
4.1.4 Australia
4.2 Cholesterol-lowering Foods and Drinks
4.2.1 Phytosterols/phytostanols
4.2.2 Wholegrains
4.2.3 Oat bran/betaglucan
4.2.4 Soya protein
4.2.5 Psyllium
4.3 Circulatory Health Foods and Drinks
4.3.1 Omega-3/DHA
4.4 Anti-Hypertensive Food and Drinks
4.4.1 Bioactive peptides
4.4.2 Potassium
4.5 Antioxidant Heart Health Foods and Drinks
5. REGULATORY OVERVIEW
5.1 EU
5.1.1 Novel foods
5.1.2 Specific labelling requirements for plant sterols enriched foods
5.1.3 Health Claims
5.2 US
5.2.1 NLEA Authorized Health Claims
5.2.2 Health Claims Based on Authoritative Statements
5.2.3 Qualified Health Claims
5.3 Japan
5.3.1 Introduction
5.3.2 Food with Nutrition Function Claims (FNFC)
5.3.3 Foods for Specified Health Uses (FOSHU)
5.3.4 Other Health food
5.3.5 Novel Food
5.4 Australia
5.4.1 Claims
5.4.2 Novel foods
5.4.3 Food supplement
6. HEART AND CIRCULATORY DISEASE
6.1 Summary
6.2 Prevalence by Country and Trends in Incidence
6.2.1 Variation in circulatory disease death rates across countries
6.2.2 Influence of gender and age on death rates from circulatory diseases 154
6.2.3 Variation in hypertensive disease death rates across countries
6.2.4 Death rates from cerebrovascular disease
6.3 Background to Cardiovascular Disease (CVD)
6.3.1 Atherosclerosis
6.3.2 Thrombosis
6.4 Risk Factors
6.4.1 Types of evidence
6.4.2 Categories of risk factors for CHD
6.4.3 Irreversible risk factors
6.4.4 Potentially Reversible Factors - Physiological
6.4.5 Lifestyle
6.4.6 Psychosocial Factors
6.4.7 Early development
6.4.8 Medical conditions that increase risk of CHD
6.4.9 Prevention
6.5 References
6.6 Further Reading
7. EFFECT OF DIET: CURRENT AND POTENTIAL HEART- HEALTH INGREDIENTS
7.1 Summary
7.2 Principal Heart Health Dietary Factors
7.2.1 Soya
7.2.2 Unsaturated fatty acids
7.2.3 Plant Sterol and Stanols
7.2.4 Dietary fibre
7.2.5 Antioxidant vitamins E and C
7.2.6 Folic acid
7.2.7 Potassium-based salt replacers
7.3 Other Up-and-coming Heart Health Ingredients
7.3.1 Carotenoids
7.3.2 Vitamins B6, B12 and B3
7.3.3 Vitamin D
7.3.4 Garlic
7.3.5 Antioxidant polyphenols and flavonoids
7.3.6 L-arginine
7.3.7 Magnesium
7.3.8 Bioactive peptides
7.3.9 Chitosan
7.3.10 Wholegrains
7.4 Less Well-proven Ingredients
7.4.1 Conjugated linoleic acid
7.4.2 Plant lignans
7.4.3 Rice bran oil (contains sterols, tocotrienols, gamma-oryzanol)
7.4.4 Coenzyme Q10
7.4.5 Betaine
7.4.6 Selenium
7.5 References
7.6 Further Reading
8. PATENT REVIEW
8.1 Summary
8.2 Cholesterol-lowering Products
8.2.1 Phytosterols and phytostanols
8.2.2 Cholesterol-lowering soya protein products
8.2.3 Soluble fibre
8.3 Circulatory Health
8.3.1 PUFA-containing products
8.4 Anti-hypertensives
8.4.1 Anti-hypertensive compositions
8.4.2 Anti-hypertensive bioactive peptides
8.5 Multiple-benefit and Miscellaneous Heart-health Products
8.6. Polyphenols and Flavonoids
9. HEART HEALTH INGREDIENTS - PROPERTIES AND AVAILABILITY
9.1 Ingredients (A-Z)
9.1.1 Antioxidant vitamins (vitamins C and E, and coenzyme Q10)
9.1.2 Antioxidant polyphenols and flavonoids
9.1.3 Arginine
9.1.4 B vitamins (vitamins B3, B6 and B12)
9.1.5 â-glucan - See Dietary fibre
9.1.6 Betaine
9.1.7 Bioactive peptides
9.1.8 Carotenoids
9.1.9 Chitosan
9.1.10 Coenzyme Q10 - See Antioxidant vitamins
9.1.11 Conjugated linoleic acid
9.1.12 Dietary fibre
9.1.13 Fibre - See Dietary fibre
9.1.14 Flaxseed
9.1.15 Folic acid
9.1.16 Garlic
9.1.17 Isoflavones - See Soya
9.1.18 Lactic acid bacteria
9.1.19 Linseed - See Flaxseed
9.1.20 Magnesium
9.1.21 Monounsaturated fatty acids (MUFAs)
9.1.22 Mushroom nutraceuticals (see also Chitosan)
9.1.23 Omega-3 polyunsaturated fatty acids (n-3 PUFAs)
9.1.24 Phytochemicals - See Antioxidant polyphenols and flavonoids
9.1.25 Phytosterol and phytostanol esters
9.1.26 Psyllium - See Dietary fibre
9.1.27 Rice bran oil
9.1.28 Salt substitutes
9.1.29 Saponins
9.1.30 Soya
9.1.31 Vitamin D
9.1.32 Tocotrienols - See Antioxidant vitamins and Rice bran oil
9.1.33 Vitamins - See Antioxidant vitamins, B vitamins and Folic acid
9.1.34 Ubiquinone - See Antioxidant vitamins
9.1.35 Wholegrains - See Dietary fibre
LIST OF TABLES
TABLE 2.I Heart Benefit Foods Market Development, 2009-2014
TABLE 2.II Heart Benefit Cereal Products: Global Market Prospects Summary
TABLE 2.III Heart Benefit Fats and Oils: Global Market Prospects Summary
TABLE 2.IV Heart Benefit Fish and Eggs: Global Market Prospects Summary
TABLE 2.V Heart Benefit Bakery Products: Global Market Prospects Summary
TABLE 2.VI Heart Benefit Soya Products: Global Market Prospects Summary
TABLE 2.VII Heart Benefit Dairy Products: Global Market Prospects Summary
TABLE 2.VIII Heart Benefit Soft Drinks: Global Market Prospects Summary
TABLE 2.IX Heart Benefit Confectionery: Global Market Prospects Summary
TABLE 3.I Heart Benefit Foods - Market Trends by Country, 2009
TABLE 3.II Heart Benefit Foods - Market Trends by Type of Product, 2009
TABLE 3.III Heart Benefit Cereal Products - Market Trends by Country, 2009
TABLE 3.IV Heart Benefit Fats and Oils - Market Trends by Country, 2009
TABLE 3.V Phytosterol/Phytostanol Spreads - Key Brands, 2009
TABLE 3.VI Omega-3/Polyunsaturated Heart Health Spreads - Key Brands, 2009 .43
TABLE 3.VII France: Anti-cholesterol Margarine Market by Volume and Value,2005- 2009
TABLE 3.VIII UK: Cholesterol-Lowering Spreads Market by Value, 2005-2009
TABLE 3.IX Australia: Cholesterol-lowering Margarine Market by Volume and Value, 2005-09
TABLE 3.X Heart Benefit Fish and Eggs - Market Trends by Country, 2009
TABLE 3.XI Heart Benefit Bakery Products - Market Trends by Country, 2009
TABLE 3.XII Heart Benefit Soya Products - Market Trends by Country, 2009
TABLE 3.XIII Heart Benefit Dairy Products - Market Trends by Country, 2009
TABLE 3.XIV Heart Health Active Health Drinks - Key Brands, 2009
TABLE 3.XV Spain: Heart Benefit Dairy Products Market by Type, 2008-2009
TABLE 3.XVI Spain: Active Health Drinks Market by Type, 2004-2008
TABLE 3.XVII Spain: Anti-Cholesterol Drinks Market by Value, 2004-2009
TABLE 3.XVIII Spain: Heart Milks Market by Volume and Value, 2006-2009
TABLE 3.XIX Spain: Heart Health Milks Market Shares, 2008
TABLE 3.XX UK: Heart Benefit Dairy Products Market by Type, 2008-2009
TABLE 3.XXI UK: Functional and Cholesterol-Lowering Yoghurt Markets, 2005-2009
TABLE 3.XXII UK: Active Health and Cholesterol-Lowering Drinks Markets, 2005- 2009
TABLE 3.XXIII Heart Benefit Soft Drinks - Market Trends by Country, 2009
TABLE 3.XXIV Heart Benefit Confectionery - Market Trends by Country, 2009
TABLE 4.I Cholesterol-lowering Foods and Drinks: New Product Activity, 2007-2009
TABLE 4.II Circulatory Health Foods and Drinks: New Product Activity, 2007-2009
TABLE 4.III Anti-Hypertensive Foods and Drinks: New Product Activity, 2007-2009
TABLE 4.IV Antioxidant Heart Health Foods and Drinks: New Product Activity, 2007- 2009
TABLE 6.I Number of Registered Death Rates for all Causes of Death and Deaths by Diseases of the Circulatory System per 100,000 Population by Country, Year and Sex
TABLE 6.II Number of Registered Death Rates from Diseases of the Circulatory System per 100,000 UK Population, by Age Group and Sex, 2006
TABLE 6.III Number of Registered Death Rates from Hypertensive Disease per 100,000 Population by Country, Year and Sex
TABLE 6.IV Number of Registered Death Rates from Cerebrovascular Disease per 100,000 Population by Country, Year and Sex
TABLE 6.V Number of Registered Death Rates from Cerebrovascular Disease per 100,000 Population by Country, Year and Sex
TABLE 6.VI Study Methods to Determine Risk and Causal Factors
TABLE 6.VII Risk Factors for Coronary Heart Disease
TABLE 6.VIII Genetic Disorders Relevant to CHD
TABLE 6.IX Blood Pressure Categories
TABLE 6.X Classification of Plasma Lipoproteins
TABLE 6.XI Relationship Between Blood Cholesterol Level and Risk of Coronary Heart Disease
TABLE 6.XII Examples of Antioxidant Defences
TABLE 6.XIII Summary of the Interrelation Between Diet and Physiological Risk Factors for Coronary Heart Disease
TABLE 6.XIV Principles of Prevention Strategies for Coronary Heart Disease
TABLE 6.XV Dietary Recommendations (Population Averages) for the Prevention of Coronary Heart Disease
TABLE 7.I Beneficial Effects of the n-3 Fatty Acids: EPA and DHA
TABLE 8.I Other Patents Relating to Phytostanols and Phytosterols
TABLE 8.II Other Patents Relating to Cholesterol-lowering Soya Products
Table 8.III Other Patents Relating to Cholesterol-lowering Soluble Fibre
TABLE 8.IV Other Patents Relating to Polyunsaturated Fatty Acids
TABLE 8.V Other Patents Relating to Anti-hypertensives
TABLE 8.VI Other Patents Relating to Bioactive Anti-hypertensive Peptides
TABLE 8.VII Other Patents Relating to Miscellaneous Heart-health Products
TABLE 8.VIII Other Patents Relating to Polyphenols and Flavonoids
LIST OF FIGURES
Figure 1 Heart Benefit Foods Market by Country, 2009
Figure 2 Heart Benefit Foods Market by Product Type, 2009
Figure 3 Plaque Formation
Figure 4 Processes Involved in Blood Clotting
Figure 5 Production of Homocysteine
